Activity Limitations and Participation Restrictions in Patients with Chronic Fatigue Syndrom—Construction of a Disease Specific Questionnaire

References

• Fukuda K, Strauss SE et al. The Chronic Fatigue Syndrome, a comprehensive approach to its definition and study. Ann Intern Med 1994; 121: 953–959.
   PubMed Web of Science ®Google Scholar
• Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH. The use of the nitro-gen mustards in the palliative treatment of carcinoma. Cancer 1948; 1: 634–656.
   Web of Science ®Google Scholar
• Schaafsma J, Osoba D. The Karnofsky performance status scale re-examina-tion: a cross-validation with the EORTC-C30. Qual Life Res 1994; 3:413–424.
   PubMed Web of Science ®Google Scholar
• Capewell S, Sudlow NfF. Performance and prognosis in patients with lung can-cer. Thorax 1990; 45: 951–956.
   PubMed Web of Science ®Google Scholar
• O'Dell MW, Lubeck DP, O'Driscoll P, Matsuno S. Validity of the Karnofsky performance status in an HIV-infected sample. J Acquir Immune Defic Syndr Hum Petrovirol 1995; 10:350–357.
   Web of Science ®Google Scholar
• Collin C, Wade DT, Davies S et al. The Barthel ADL index: a reliability study. Int Disabil Studies 1988; 10:61–63.
   PubMedGoogle Scholar
• Wade DT, Collin C. The Barthel ADL index: a standard measure of physical disability? Int Disabil Studies 1988; 10:64–67.
   PubMedGoogle Scholar
• Lloyd A, Hickie et al. A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome. Am J Med 1990; 89: 561–568.
   PubMed Web of Science ®Google Scholar
• Sharpe MC, Archard LC, Banatvala JE et al. A report on Chronic Fatigue Syn-drome: guidelines for research. J R Soc Med 1991; 84:118–121.
   PubMed Web of Science ®Google Scholar
• Anderson JS, Ferrans CE. The quality of life of persons with chronic fatigue syndrome. J Nerv Ment Dis 1997; 185(6): 359–367.
   PubMed Web of Science ®Google Scholar
• Ferrans CE, Powers MJ. Psychometric assessment of the quality of life index. Res Nurs Health 1992; 15: 29–38.
   PubMed Web of Science ®Google Scholar
• Ferrans CE, Powers MJ. Quality of Life Index: development and psychometric properties. Adv Nurs Sci 1985; 8(1): 15–24.
   PubMed Web of Science ®Google Scholar
• Barrows DM. Functional capacity evaluations of persons with chronic fatigue immune dysfunction syndrome. Am J Occup Ther 1995; 49(4): 327–337.
   PubMed Web of Science ®Google Scholar
• Buchwald D, Herrell R et al. The Chronic Fatigue Twin Registry: method of construction, composition, and zygosity assignment. Twin Res 1999; 2:203–211.
   PubMedGoogle Scholar
• Buchwald D, Pearlman T et al. Functional status in patients with chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals. Am J Med 1996; 101:364–370.
   PubMed Web of Science ®Google Scholar
• Buchwald D, Pearlman T et al. Gender differences in patients with chronic fa-tigue syndrome. J Gen Intern Med 1994; 9:397–401.
   PubMed Web of Science ®Google Scholar
• Buskila D. Fibromyalgia, chronic fatigue syndrome, and myofascial pain syn-drome. Curr Opin Rheumatol 1999; 11:119–126.
   PubMedGoogle Scholar
• Christodoulou C, Deluca J et al. Relation between neuropsychological impair-ment and functional disability in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 1998; 64:431–434.
   PubMed Web of Science ®Google Scholar
• Clark MR, Katon W et al. Chronic fatigue: risk factors for symptoms persis-tence in a 2.5-year follow-up study. Am J Med 1995; 98: 187–195.
   Google Scholar
• Deale A, Chalder T, Marks I, Wessely S. Cognitive behavior therapy for chroniuc fatigue syndrome: a randomised controlled trial. Am J Psychiatry 1997; 154(3):408–414.
   PubMed Web of Science ®Google Scholar
• Deale A, David AS. Chronic fatigue syndrome: evaluation and management. J Neuropsychiatry 1994; 6(2):189–194.
   PubMed Web of Science ®Google Scholar
• Euba R, Chalder T, Deale A, Wessely S. A comparison of the characteristics of chronic fatigue syndrome in primary and tertiary care. Br J Psychiatry 1996; 168:121–126.
   PubMed Web of Science ®Google Scholar
• Fishler B, Dendale Petal. Physical fatigability and exercise capacity in chronic fatigue syndrome: association with disability, somatization and psychopathology. J Psychosom Res 1997; 42(4):369–378.
   PubMed Web of Science ®Google Scholar
• Fishier B, Le Bon O et al. Sleep anomalies in the chronic fatigue syndrome. Neuropsychobiol 1997; 35:115–122.
   Google Scholar
• Fisk JD, Ritvo PG et al. Measuring the functional impact of fatigue: initial vali-dation of the fatigue impact scale. Clin Infect Dis 1994; 18(S1): S79–S83.
   PubMedGoogle Scholar
• HaMs F, Waalen J, Mior S. Psychometric properties of the Neck Disabilty In-dex. J Manipulative Physiol Ther 1998; 21(2):75–80.
   PubMedGoogle Scholar
• ICIDH-2: International Classification of Functioning and Disability. Beta-2 draft, Short Version. Geneva, World Health Organisation, 1999.
   Google Scholar
• Jason LA, King CP, Frankenberry EL, Jordan KM, Tryon WW, Rademaker F, Huang C-F. Chronic fatigue syndrome: assessing symptoms and activity level. J Clin Psychol 1999; 55(4): 411–424.
   Google Scholar
• Jefferies CR, Weir WRC. Coping with chronic fatigue syndrome: illness re-sponses and their relationship with fatigue, functional impairment and emotional sta-tus. Psychol Med 1995; 25:937–945.
   PubMed Web of Science ®Google Scholar
• Katon W, Russo J. Chronic fatigue syndrome criteria. Arch Intern Med 1992; 152:1604–1609.
   PubMed Web of Science ®Google Scholar
• Komaroff AL, Fagioli LR et al. Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. Am J Med 1996; 101:281–290.
   PubMed Web of Science ®Google Scholar
• Lloyd A, Hickie I et al. A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome. Am J Med 1990; 89:561–568.
   PubMed Web of Science ®Google Scholar
• Lloyd AR, Hickie I et al. Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. Am J Med 1993; 94:197–203.
   PubMed Web of Science ®Google Scholar
• Lutgendorf SK, Antoni MH et al. Physical symptoms of chronic fatigue syn-drome are exacerbated by the stress of Hurricane Andrew. Psychosom Med 1995; 57:310–323.
   PubMed Web of Science ®Google Scholar
• Machale SM, Cavanogh JTO et al. Diurnal variation of adrenocortical activity in chronic fatigue syndrome. Neuropsychobiol 1998; 38:213–317.
   PubMed Web of Science ®Google Scholar
• Manu P, Affleck G, Tennen H, Morse PA, Escobar JI. Hypochondriasis influ-ence quality-of-life outcomes in patients with chronic fatigue. Psychother Psychosom 1996; 65:76–81.
   Google Scholar
• Natelson BH, Vheu Jet al. Single-blind, placebo phase-in trial of two escalating doses of selegiline in the chronic fatigue syndrome. Neuropsychobiol 1998; 37:150–154.
   PubMed Web of Science ®Google Scholar
• Natelson BH, Johnson SK et al. Reducing heterogenity in chronic fatigue syn-drome: a comparison with depression and multiple sclerosis. Clin Infect Dis 1995; 21:1204–1210.
   PubMed Web of Science ®Google Scholar
• Petrie K, Moss-Morris R, Weinman J. The impact of catastrophic beliefs on functioning in chronic fatigue syndrome. J Psychosom Res 1995; 39(1):31–37.
   PubMed Web of Science ®Google Scholar
• Peterson PK, Pheley A et al. A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome. Arch Intern Med 1998; 158:908–914.
   PubMed Web of Science ®Google Scholar
• Peterson PK, Shepard J et al. A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome. Am J Med 1990; 89:554–560.
   PubMed Web of Science ®Google Scholar
• Ray C, Jefferies S, Weir WRC. Coping and other predictors of outcome in chronic fatigue syndrome: a 1-year follow-up. J Psychosom Res 1997; 43(4): 405–415.
   Google Scholar
• Saltzstein BJ, Wyshal G et al. A naturalistic study of the chronic fatigue syn-drome among women in primary care. Gen Hosp Psychiatry 1998; 20:307–316.
   PubMed Web of Science ®Google Scholar
• Schmaling KB, Smith WR, Buchwald DS. Significant other responses are asso-ciated with fatigue and functional status among patients with chronic fatigue syn-drome. Psychosom Med 2000; 62:444–450.
   Google Scholar
• Schwartz SN, Jones R. Measuring outcomes of treatment in chronic fatigue syn-drome: a comparison of simple questioning vs. use of validated outcome instrument (Short Form 36). Journal of Chronic Fatigue Syndrome 2000; 6(2):3–10.
   Google Scholar
• See DM, Tilles JG. Alpha-interferon treatment of patients with chronic fatigue syndrome. Immunol Invest 1996; 25:153–164.
   PubMed Web of Science ®Google Scholar
• Sharpe M, Hawton K, Seargroatt V, Pasvol G. Follow up of patients presenting with fatigue to an infectious diseases clinic. BMJ 1992; 305:147–152.
   PubMed Web of Science ®Google Scholar
• Sharpe M, Hawton K et al. Cognitive behaviour therapy for the chronic fatigue syndrome: a randomised controlled trial. BMJ 1996; 312:22–26.
   PubMed Web of Science ®Google Scholar
• Smeenk S. Kwaliteit van het leven en het chronische vermoeidheidssyndroom. Tijdschrift voor Gezondheidswetenschappen 2000; 3:78.
   Google Scholar
• Vercoulen JHMM, Hommes OR et al. The Measurement of fatigue in patients with multiple sclerosis. Arch Neurol 1996; 53:642–649.
   PubMed Web of Science ®Google Scholar
• Vercoulen JHM1VI, Swanink CMA, Galama JMD et al. The persistence of fa-tigue in chronic fatigue syndrome and multiple sclerosis; development of a model. J Psychosom Res 1998; 45(6):507–517.
   Google Scholar
• Vercoulen JHMM, Swanink CMA, Fermis JFM et al. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 1994; 38(5):383–392.
   PubMed Web of Science ®Google Scholar
• Vercoulen JHMM, Swanink CMA, Zitman FG et al. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 1996; 347:858–861.
   PubMed Web of Science ®Google Scholar
• Vernon H, Mior S. The Neck Disability Index: a study of reliability and validity. J Manipulative Physiol Ther 1991; 14(7):409–415.
   PubMed Web of Science ®Google Scholar
• Vollmer-Conna U, Hickie et al. Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome. Am J Med 1997; 103:38–43.
   PubMed Web of Science ®Google Scholar
• Wessely S Chalder T et al. Psychological symptoms, somatic symptoms, and psychiatric disorder in chronic fatigue syndrome: a prospective study in the primary care setting. Am J Psychiatry 1996; 153(8):1050–1059.
   PubMed Web of Science ®Google Scholar
• Wilson A, Hickie A, Lloyd A et al. Longitudinal study of outcome of chronic fa-tigue syndrome. BMJ 1994; 308: 756–759.
   PubMed Web of Science ®Google Scholar
• Follick MJ, Ahem DK, Laser-Walston N. Evaluation of a daily activity diary for chronic pain patients. Pain 1984; 19:373–382.
   Google Scholar
• Luteijn F, Hamel LF, Bouwman TK, Kok AR. Hopkins Symptom Shacklist: handleiding. Lisse: Swets & Zeitlinger 1984. p. 10.
   Google Scholar
• Howe S, Levinson J, Shear E et al. Development of a disability measurement tool for juvenile rheumatoid arthritis. Arthritis Rheum 1991; 34(7):873–880.
   PubMed Web of Science ®Google Scholar
• Mannerkorpi K, Ekdahl C. Assessment of functional limitation and disability in patients with fibromyalgia. Scand J Rheumatol 1997; 26:4–13.
   PubMed Web of Science ®Google Scholar
• Hinderer SR, Rondinelli RD, Katz RT. Measurement issues in impairment rat-ing and disability evaluation. Chapter 3 in: Rondinelli RD, Katz RT (eds.). Impairment Rating and Disability Evaluation. Philadelphia: Saunders Company 2000. pp. 35–52.
   Google Scholar
• Holmes GP, Kaplan JE, Gantz NM et al. Chronic Fatigue Syndrome, a working case definition. Ann Intern Med 1988; 108:387–389.
   PubMed Web of Science ®Google Scholar
• Peterson DL. Chronic Fatigue Syndrome and disability: editorials. Journal of Chronic Fatigue Syndrome 1997; 3(4): 5–7.
   Google Scholar
• De Becker P, Roeykens J, Reynders M et al. Exercise capacity in Chronic Fa-tigue Syndrome. Arch Intern Med 2000; 160:3270–3277.
   PubMed Web of Science ®Google Scholar
• Klimas NG. Chronic Fatigue Syndrome and disability: introduction. Journal of Chronic Fatigue Syndrome 1997; 3(4):1–3.
   Google Scholar
• World Health Organisation. International Classification of Impairments, Dis-abilities, and Handicaps. Geneva: WHO, 1980.
   Google Scholar
• Simeonsson RJ, Lollar D, Hollewell Jet al. Revision of the International Classi-fication of Impairments, Disabilities, and Handicaps: developmental issues. J Clin Epidemiol 2000; 53:113–124.
   Google Scholar
• Bickenbach JE, Chatterji S, Hadley EM, Ustiin TB. Models of disablement, uni-versalism and the international classification of impairments, disabilities and handi-caps. Soc Sci Med 1999; 48:1173–1187.
   PubMed Web of Science ®Google Scholar
• Burkhardt CS, Clark SR, Bennett RM. The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 1991; 18(5):728–733.
   Google Scholar
• Reber AS. Woordenboek van de psychologie: uitgebreide en herziene editie. Amsterdam: Uitgevereij Bert Bakker. 1997. p. 455.
   Google Scholar
• Sharpe M, Hawton K, Simkin S, Surawy C, Hackmann A, Klimes I, Peto T, Warrell D, Seagroatt V. Cognitive behaviour therapy for the chronic fatigue syndrome: a randomised controlled trial. BMJ 1996; 312: 22–26.
   Google Scholar